Combination Therapy May Increase Lesion Closure in PCV - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Combination Therapy May Increase Lesion Closure in PCV

The combination of photodynamic therapy and intravitreal  aflibercept did not improve 1-year visual acuity outcomes compared with aflibercept monotherapy.

  • By

  • Andrea Surnit

  • May 13, 2026

  • 3 min

Share

Original Source(s)

Combination Therapy May Increase Lesion Closure in PCV

  • by Andrea Surnit

  • May 13, 2026

Related Content

Benchmark for Functional Vision Loss Uncovered in Older Adults

A nationally representative US cohort identified a contrast sensitivity threshold associated with self-reported visual disability.

Dana-Farber’s Momentum of Discovery

William G. Kaelin Jr., MD won the Nobel Prize for discovering how cancer grows and multiplies by hijacking the body’s oxygen-sensing system, which led to a new class of oxygen-regulating drugs.

  • February 7, 2022

  • 1 min
Can Oral Gildeuretinol Slow Advanced Macular Degeneration?

Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.